undamentalytics Newsletter
Sign in

Sanuwave Health, Inc. cash flow statement

In fiscal 2025, Sanuwave Health, Inc.'s operations generated $3.9m of cash; it spent $1.9m on capital projects, leaving free cash flow of $1.9m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−6−9−4−4−7−3−3−2−4−6−13−6−17−5245
Depreciation and amortisation10000000000111111
Stock-based pay311101112000—0256
Capital spending—00—0—000001—0021
Free cash flow—−9−4—−7—−3−2−4−6−13−7—−5224
Free cash flow after stock pay—−10−6—−7—−4−2−6−7−13−7—−50−3−2
Shares issued2—021—20—————0100—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: MYO vs SNWVSNWV vs TLSIKRMD vs SNWVCLPT vs SNWV

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sanuwave Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sanuwave Health, Inc.